Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

A multidisciplinary approach for patients with multiple chronic conditions: IMPACTO study.

Nieto-Martín MD, De la Higuera-Vila L, Bernabeu-Wittel M, González-Benitez MA, Alfaro-Lara ER, Barón-Ramos MA, Montero-Aparicio E, Aparicio-Santos R, Baturone MO; list of researchers involved in the IMPACTO study and their affiliations.

Med Clin (Barc). 2019 Mar 8. pii: S0025-7753(19)30060-0. doi: 10.1016/j.medcli.2019.01.014. [Epub ahead of print] English, Spanish.

PMID:
30857796
2.

Association Between Drug Burden Index and Functional and Cognitive Function in Patients with Multimorbidity.

Villalba-Moreno AM, Alfaro-Lara ER, Rodríguez-Pérez A, Báñez-Toro D, Sánchez-Fidalgo S, Pérez-Guerrero MC, Santos-Ramos B, Nieto-Martín MD.

Curr Pharm Des. 2018;24(28):3384-3391. doi: 10.2174/1381612824666180327154239.

PMID:
29589542
3.

[Deprescribing: guiding its definition].

Rodríguez-Pérez A, Santos-Ramos B, Alfaro-Lara ER.

Farm Hosp. 2017 Nov 1;41(6):698-699. doi: 10.7399/fh.10848. Spanish. No abstract available.

4.

Development of the Anticholinergic Burden Calculator Web Tool.

Villalba-Moreno Á, Alfaro-Lara ER, Sánchez-Fidalgo S, Nieto-Martín MD, Santos-Ramos B.

Farm Hosp. 2017 Sep 1;41(5):647-648. doi: 10.7399/fh.10799. No abstract available.

5.

Development of a Trigger Tool to Identify Adverse Drug Events in Elderly Patients With Multimorbidity.

Toscano Guzmán MD, Galván Banqueri M, Otero MJ, Alfaro Lara ER, Casajus Lagranja P, Santos Ramos B.

J Patient Saf. 2017 Jun 14. doi: 10.1097/PTS.0000000000000389. [Epub ahead of print]

PMID:
28617720
6.

Novel tool for deprescribing in chronic patients with multimorbidity: List of Evidence-Based Deprescribing for Chronic Patients criteria.

Rodríguez-Pérez A, Alfaro-Lara ER, Albiñana-Perez S, Nieto-Martín MD, Díez-Manglano J, Pérez-Guerrero C, Santos-Ramos B.

Geriatr Gerontol Int. 2017 Nov;17(11):2200-2207. doi: 10.1111/ggi.13062. Epub 2017 May 21.

PMID:
28544188
7.

[Methodological guideline for the efficacy and safety assessment of new pharmaceuticals: implementation of EUnetHTA's recommendations].

Ubago Pérez R, Castillo Muñoz MA, Banqueri MG, García Estepa R, Alfaro Lara ER, Vega Coca MD, Beltrán Calvo C, Molina López T.

Gac Sanit. 2017 Jul - Aug;31(4):336-341. doi: 10.1016/j.gaceta.2016.10.005. Epub 2017 Jan 3. Spanish.

8.

Degree of Anticoagulation Control in Patients With Atrial Fibrillation in Spain: Need to Minimize Biases and Contextualize Results.

Alfaro-Lara ER, García-Estepa R, Molina-López T.

Rev Esp Cardiol (Engl Ed). 2016 Mar;69(3):355. doi: 10.1016/j.rec.2015.11.007. Epub 2016 Feb 1. No abstract available.

PMID:
26838060
9.

Systematic review on the use of anticholinergic scales in poly pathological patients.

Villalba-Moreno AM, Alfaro-Lara ER, Pérez-Guerrero MC, Nieto-Martín MD, Santos-Ramos B.

Arch Gerontol Geriatr. 2016 Jan-Feb;62:1-8. doi: 10.1016/j.archger.2015.10.002. Epub 2015 Oct 14. Review. Erratum in: Arch Gerontol Geriatr. 2016 May-Jun;64:178-80.

PMID:
26518612
10.

Continuous versus intermittent piperacillin/tazobactam infusion in infection due to or suspected pseudomonas aeruginosa.

Cotrina-Luque J, Gil-Navarro MV, Acosta-García H, Alfaro-Lara ER, Luque-Márquez R, Beltrán-García M, Bautista-Paloma FJ.

Int J Clin Pharm. 2016 Feb;38(1):70-9.

PMID:
26474861
11.

Anticholinergic risk: Use and limitations of anticholinergic scales.

Villalba-Moreno AM, Alfaro-Lara ER, Santos-Ramos B.

Eur J Intern Med. 2015 Dec;26(10):e65-6. doi: 10.1016/j.ejim.2015.08.014. Epub 2015 Sep 10. No abstract available.

PMID:
26365371
12.

Deprescribing in patients with multimorbidity: a necessary process.

Rodríguez Pérez A, Alfaro Lara ER, Nieto Martín MD, Ruiz Cantero A, Santos Ramos B.

Eur J Intern Med. 2015 Sep;26(7):e18-9. doi: 10.1016/j.ejim.2015.06.011. Epub 2015 Jul 4. No abstract available.

PMID:
26148432
13.

Factors related with the appropriateness of pharmacological treatment in polypathological patients.

Galván Banqueri M, Alfaro Lara ER, Rincón Gómez M, Rivas Covas PC, Vega Coca MD, Nieto Martín MD.

Farm Hosp. 2014 Sep 16;38(5):405-10. doi: 10.7399/fh.2014.38.5.7504.

14.

[Visa at a tertiary hospital].

Martínez-Jiménez S, Lluch-Colomer A, Desongles-Corrales T, Bernal-González D, Santos-Rubio MD, Alfaro-Lara ER, Galván-Banqueri M.

Farm Hosp. 2013 Sep-Oct;37(5):406-11. doi: 10.7399/FH.2013.37.5.771. Spanish.

15.

Assessment of new drugs in a tertiary hospital using a standardized tool.

González-Bueno J, Chamorro-de-Vega E, Alfaro-Lara ER, Galván-Banqueri M, Santos-Ramos B.

Farm Hosp. 2013 Sep-Oct;37(5):388-93. doi: 10.7399/FH.2013.37.5.763.

16.

[Pharmacological treatment conciliation methodology in patients with multiple conditions].

Alfaro-Lara ER, Vega-Coca MD, Galván-Banqueri M, Nieto-Martín MD, Pérez-Guerrero C, Santos-Ramos B.

Aten Primaria. 2014 Feb;46(2):89-99. doi: 10.1016/j.aprim.2013.07.002. Epub 2013 Sep 12. Review. Spanish.

17.

[Medication reconciliation on hospital admission in patients with multiple chronic diseases using a standardised methodology].

Alfaro-Lara ER, Santos-Ramos B, González-Méndez AI, Galván-Banqueri M, Vega-Coca MD, Nieto-Martín MD, Ollero-Baturone M, Pérez-Guerrero C.

Rev Esp Geriatr Gerontol. 2013 May-Jun;48(3):103-8. doi: 10.1016/j.regg.2012.11.011. Epub 2013 Mar 23. Spanish.

PMID:
23528264
18.

[Health care models for patients with multiple chronic conditions and the role of the hospital pharmacy/the hospital pharmacist].

Santos-Ramos B, Otero López MJ, Galván-Banqueri M, Alfaro-Lara ER, Vega-Coca MD, Nieto-Martín MD, Ollero-Baturone M.

Farm Hosp. 2012 Nov-Dec;36(6):506-17. doi: 10.7399/FH.2012.36.6.52. Review. Spanish.

19.

[Evaluation of the appropriateness of pharmacotherapy in patients with high comorbidity].

Galván-Banqueri M, González-Méndez AI, Alfaro-Lara ER, Nieto-Martín MD, Pérez-Guerrero C, Santos-Ramos B.

Aten Primaria. 2013 May;45(5):235-43. doi: 10.1016/j.aprim.2012.11.010. Epub 2013 Jan 18. Spanish.

20.

[Suitability of pharmacological treatment in patients with multiple chronic conditions].

Galván-Banqueri M, Santos-Ramos B, Vega-Coca MD, Alfaro-Lara ER, Nieto-Martín MD, Pérez-Guerrero C.

Aten Primaria. 2013 Jan;45(1):6-18. doi: 10.1016/j.aprim.2012.03.011. Epub 2012 Dec 6. Review. Spanish.

21.

Selection of tools for reconciliation, compliance and appropriateness of treatment in patients with multiple chronic conditions.

Alfaro Lara ER, Vega Coca MD, Galván Banqueri M, Marín Gil R, Nieto Martín MD, Pérez Guerrero C, Ollero Baturone M, Santos-Ramos B.

Eur J Intern Med. 2012 Sep;23(6):506-12. doi: 10.1016/j.ejim.2012.06.007. Epub 2012 Jun 26.

PMID:
22863426
22.

[The use and suitability of absorbent products for urinary incontinence in a primary health care district].

Alfaro-Lara ER, Palma-Morgado D, Hevia-Álvarez E, de la O Caraballo-Camacho M, López IF, Domínguez-Camacho JC, Desongles-Corrales T.

Enferm Clin. 2011 Nov-Dec;21(6):320-6. doi: 10.1016/j.enfcli.2011.07.016. Epub 2011 Nov 22. Spanish.

PMID:
22112965
23.

[Analysis of the selection process for new drugs in a tertiary hospital 2004-2007].

Alfaro-Lara ER, Galván-Banqueri M, Prado-Mel E, Santos-Ramos B, Varela-Aguilar JM, Torelló-Iserte J, Castellano Zurera MM, Bautista Paloma FJ.

Farm Hosp. 2010 Mar-Apr;34(2):76-84. doi: 10.1016/j.farma.2009.09.004. Epub 2010 Jan 25. Spanish.

PMID:
20304366

Supplemental Content

Loading ...
Support Center